Clinical Trial Update: The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Raphamin for acute rhinosinusitis in adults is currently recruiting, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Raphamin (Raphamin)

Snippet

Sponsor: Materia Medica Holding | Conditions: Rhinosinusitis, Rhinosinusitis Acute | Phase 3 | Status: RECRUITING